共 50 条
- [41] COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR THE TREATMENT OF PEYRONIE'S DISEASE - A SINGLE CENTRE EXPERIENCE JOURNAL OF SEXUAL MEDICINE, 2023, 20 : 63 - 63
- [43] PEYRONIE'S DISEASE: THE IMPACT OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ON DIAGNOSIS, TREATMENT, AND COST JOURNAL OF UROLOGY, 2018, 199 (04): : E883 - E883
- [44] INCIDENCE OF SECONDARY INTERVENTION FOR PEYRONIE'S DISEASE AFTER COLLAGENASE CLOSTRIDIUM HISTOLYTICUM JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S36 - S36
- [45] REASONS OF DISCONTINUATION FROM COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENTS IN PEYRONIE'S DISEASE JOURNAL OF SEXUAL MEDICINE, 2023, 20
- [46] Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 431 - 448
- [47] An illustrated description of a modified collagenase Clostridium histolyticum protocol for Peyronie's disease JOURNAL OF SEXUAL MEDICINE, 2024, 21 (12): : 1169 - 1177
- [48] THE SAFETY AND EFFICACY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN COMBINATION WITH VACUUM THERAPY FOR THE TREATMENT OF PEYRONIE'S DISEASE JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E1 - E2
- [50] OCCURRENCE OF ADVERSE EVENTS DOES NOT IMPACT EFFICACY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM THERAPY FOR PEYRONIE'S DISEASE JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S109 - S109